STATİNS REVERSE DOXORUBİCİN RESİSTANCE İN MESOTHELİOMA CELLS
Genel
Statins Reverse Doxorubicin Resistance in Mesothelioma Cells NEW YORK JUL 12, 2006 (Reuters Health) – Statins reverse doxorubicin resistance in human malignant mesothelioma cells in culture, a finding that may lead to new clinical strategies to improve doxorubicin efficacy in this hard to treat Devamını Oku..